Images
Cordis, the internet gateway to Research and Development in the European Union, echoes the work performed by Miquel Coll, coordinator of the Computational and Structural Biology programme. Coll's research, which is partly funded by the European Union as part of SPINE2-COMPLEXES project within the Sixth Framework Programme, presents encouraging results with regards herpes viruses. This family of viruses is the cause of many diseases, such as cold sores, genital herpes, chickenpox, etc., and the most recent study published by these researchers at IRB Barcelona suggests that these viruses could be treated with a drug for AIDS that is already on the market.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
